Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in News & Analysis

Hansoh Signs $1.3 Billion siRNA Deal; Its Second siRNA Deal in a Week
Innovent Says PD-1 Meets Survival Endpoint in Phase III NSCLC Trial
Week in Review: Hansoh Signs $456 Million Deal for siRNA Products
Abbisko Raises $226 Million in Hong Kong IPO for Cancer Therapies
GV20 Oncotherapy Closes Series B for Genomics/AI-based mAb Portfolio 
ChinaBio Event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China